AP2007003915A0 - Anti-histaminic composition - Google Patents

Anti-histaminic composition

Info

Publication number
AP2007003915A0
AP2007003915A0 AP2007003915A AP2007003915A AP2007003915A0 AP 2007003915 A0 AP2007003915 A0 AP 2007003915A0 AP 2007003915 A AP2007003915 A AP 2007003915A AP 2007003915 A AP2007003915 A AP 2007003915A AP 2007003915 A0 AP2007003915 A0 AP 2007003915A0
Authority
AP
ARIPO
Prior art keywords
histaminic
composition
histaminic composition
Prior art date
Application number
AP2007003915A
Other languages
English (en)
Inventor
Sankarnarayanan Anand
Geena Malhotra
Amar Lalla
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AP2007003915A0 publication Critical patent/AP2007003915A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
AP2007003915A 2004-07-16 2005-07-18 Anti-histaminic composition AP2007003915A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN765MU2004 2004-07-16
PCT/GB2005/002828 WO2006008512A2 (en) 2004-07-16 2005-07-18 Anti-histaminic composition

Publications (1)

Publication Number Publication Date
AP2007003915A0 true AP2007003915A0 (en) 2007-02-28

Family

ID=35539416

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003915A AP2007003915A0 (en) 2004-07-16 2005-07-18 Anti-histaminic composition

Country Status (16)

Country Link
US (1) US20070281960A1 (es)
EP (1) EP1778195A2 (es)
JP (1) JP2008506679A (es)
KR (1) KR20070053221A (es)
AP (1) AP2007003915A0 (es)
AU (1) AU2005263958B2 (es)
BR (1) BRPI0513417A (es)
CA (1) CA2574188A1 (es)
EC (1) ECSP077262A (es)
IL (1) IL180724A0 (es)
MA (1) MA28801B1 (es)
MX (1) MX2007000632A (es)
NZ (1) NZ552998A (es)
TN (1) TNSN07013A1 (es)
WO (1) WO2006008512A2 (es)
ZA (1) ZA200701036B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
DK1698630T3 (da) 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
GB0702837D0 (en) * 2007-02-14 2007-03-28 Boc Group Plc Method of treating a gas stream
EP2167084B1 (en) * 2007-06-12 2013-04-24 ALK-Abelló A/S An allergen dosage form comprising an antihistamine
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
WO2011141483A2 (en) 2010-05-10 2011-11-17 Laboratorios Lesvi, S.L. Stable pharmaceutical formulations containing an antihistaminic
JP6072778B2 (ja) * 2011-05-23 2017-02-01 シーイーエム—１０２ ファーマシューティカルズ，インコーポレイテッド フシジン酸を含む組成物およびそのためのパッケージ
CN109498585B (zh) * 2018-12-21 2019-09-10 扬子江药业集团广州海瑞药业有限公司 一种枸地氯雷他定片剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU194864B (en) * 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
AU2407597A (en) * 1997-04-25 1998-11-24 Schering-Plough Kabushiki Kaisha Eyedrops
US6506767B1 (en) * 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
DE69916042T2 (de) * 1998-07-10 2004-11-11 Schering Corp. Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
DK1994834T3 (da) * 2002-09-24 2010-08-09 Gumlink As Tyggegummi med lavt fugtighedsindhold
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
CN100563654C (zh) * 2003-07-22 2009-12-02 范敏华 一种地氯雷他定分散片及其制备方法
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
EP1696881A2 (en) * 2003-12-23 2006-09-06 Sun Pharmaceutical Industries Limited Stable oral composition

Also Published As

Publication number Publication date
JP2008506679A (ja) 2008-03-06
MA28801B1 (fr) 2007-08-01
ECSP077262A (es) 2007-03-29
AU2005263958A1 (en) 2006-01-26
IL180724A0 (en) 2007-07-04
NZ552998A (en) 2010-11-26
EP1778195A2 (en) 2007-05-02
AU2005263958B2 (en) 2011-04-14
CA2574188A1 (en) 2006-01-26
KR20070053221A (ko) 2007-05-23
MX2007000632A (es) 2007-03-30
ZA200701036B (en) 2008-05-28
US20070281960A1 (en) 2007-12-06
BRPI0513417A (pt) 2008-05-06
WO2006008512A3 (en) 2006-08-03
WO2006008512A2 (en) 2006-01-26
TNSN07013A1 (en) 2008-06-02

Similar Documents

Publication Publication Date Title
GB0409375D0 (en) Phytoactive composition
EP1930012A4 (en) COMPOSITION CONTAINING A CELLO-OLIGOSACCHARIDE
EP1726304A4 (en) COMPOSITION CONTAINING SOLIFENACIN
EP1865042A4 (en) ANTI-FREEZE COMPOSITION
GB0508250D0 (en) Composition
GB0506044D0 (en) Composition
EP1847249A4 (en) hair dye
IL180724A0 (en) Anti-histaminic composition
GB0507167D0 (en) Composition
GB0425795D0 (en) Composition
GB0410038D0 (en) Composition
GB0416861D0 (en) Composition
GB0414803D0 (en) Composition
ZA200704974B (en) Composition
EP1947129A4 (en) PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION
EP1864573A4 (en) AGRICULTURAL CHEMICAL COMPOSITION
GB0415981D0 (en) Composition
GB0417357D0 (en) Composition
GB0502341D0 (en) Composition
GB0513641D0 (en) Anti-egeing composition
GB0510286D0 (en) Composition
GB0417388D0 (en) Composition
GB2418924B (en) Weathered-effect composition
GB0409598D0 (en) Composition
GB0415329D0 (en) Composition